1.
J Med Chem
; 46(15): 3197-200, 2003 Jul 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12852750
RESUMO
(S)-N-[1-(3-Morpholin-4-ylphenyl)ethyl]-3-phenylacrylamide (2) was synthesized as an orally bioavailable KCNQ2 potassium channel opener. In a rat model of migraine, 2 demonstrated significant oral activity in reducing the total number of cortical spreading depressions induced by potassium chloride.